The Cell and Gene Therapy Catapult: consortium formed for improvement of manufacturing processes

Written by Alice Bough

CD34+

The Cell and Gene Therapy Catapult (London, UK), with the support of Innovate UK (Swindon, UK), have formed a consortium of over 20 organizations to advance technology development in the fields of cell and gene therapy. The consortium will work to assess the applications of new and already used process analytical technologies in the context of the cell and gene therapy industry. By working together and sharing data between them, they want to improve monitoring of manufacturing processes, allowing a reduction in batch failures and manufacturing costs. “The industry needs to make a giant leap in terms of analytical capability...

To view this content, please register now for access

It's completely free